Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-146349)

Filing Details

Accession Number:: 0001104659-16-146349
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-23 20:50:50
Reporting Period:: 2016-09-21

Filing Date:: 2016-09-23
Accepted Time:: 2016-09-23 20:50:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1491576	Tesaro Inc.	TSRO	Pharmaceutical Preparations (2834)	272249687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1653276	Jr. H. Martin Huber	C/O Tesaro, Inc. 1000 Winter Street, Suite 3300 Waltham MA 02451	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-09-21	1,250	$0.00	1,250	No	4	M	Direct
Common Stock	Disposition	2016-09-22	408	$108.12	842	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2016-09-21	1,250	$0.00	1,250	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,750			No	4	M	Direct

Footnotes

Restricted stock units convert into common stock on a one-for-one basis.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
On September 21, 2015, the reporting person was granted 5,000 restricted stock units, vesting in in four equal annual installments beginning September 21, 2016.